Please login to the form below

Not currently logged in
Email:
Password:

market data

This page shows the latest market data news and features for those working in and with pharma, biotech and healthcare.

Biogen and AbbVie pull MS drug Zinbryta from the market

Biogen and AbbVie pull MS drug Zinbryta from the market

Biogen and AbbVie pull MS drug Zinbryta from the market. Potential risks of liver damage and immune-related conditions have been reported. ... Biogen and AbbVie have voluntarily withdrawn their multiple sclerosis drug Zinbryta from the market worldwide,

Latest news

  • AZ’s COPD triple data sets up market clash with GSK AZ’s COPD triple data sets up market clash with GSK

    AZ’ s COPD triple data sets up market clash with GSK. ... for a sizeable slice of the $14.1bn overall COPD market in that year in nine countries - the US, France, Germany, Italy, Spain, the UK, Japan, and Australia.

  • New data could unlock bigger market for Roche’s Hemlibra New data could unlock bigger market for Roche’s Hemlibra

    New data could unlock bigger market for Roche’ s Hemlibra. Trial shows it ‘significantly’reduced bleeds in some haemophilia A patients. ... Now, data from the phase III  HAVEN 3 trial show that the drug was able to significantly reduce bleeds in

  • Takeda dengue vaccine data looks good as it chases Sanofi Takeda dengue vaccine data looks good as it chases Sanofi

    Takeda dengue vaccine data looks good as it chases Sanofi. TAK-003 achieved a 71% reduction in developing the virus compared to placebo. ... Takeda’s chances of stealing a march on rival Sanofi in the dengue fever vaccine market look increasingly high

  • AbbVie risankizumab trials set up psoriasis filing - and a market battle AbbVie risankizumab trials set up psoriasis filing - and a market battle

    secukinumab) which is making rapid headway in the market and is starting to generate compelling long-term efficacy and safety data. ... Phase II data in psoriatic arthritis is due shortly, with phase III studies expected to begin in the first half of 2018

  • Belgium's Ablynx enters the US market Belgium's Ablynx enters the US market

    Belgium's Ablynx enters the US market. The biopharma firm's new subsidiary will be led by Daniel Schneider. ... Belgium biopharmaceutical company Ablynx has established a beachhead in the US, setting up a new subsidiary for that market.

More from news
Approximately 5 fully matching, plus 121 partially matching documents found.

Latest Intelligence

  • Market research

    Healthcare terms - Market research.

  • Pushing the accelerator Pushing the accelerator

    Improved visibility into data will drive faster and better decision-making across the organisation. ... and market data, or to automatically reallocate manufacturing capacity to avoid product shortages.

  • Beyond the annual plan Beyond the annual plan

    Beyond the annual plan. Seven steps to creating a successful strategic  plan in a hyper-competitive market. ... The best way to adjust the plan is also the simplest - set up strategic review meetings that align with critical market events, such as data

  • Proving real-world value Proving real-world value

    An R&D model enhanced by real-world data ensures momentum to market. ... We create thousands of patient leaflets because market research says patients like them.

  • Managing medication non-adherence Managing medication non-adherence

    market quickly and start gathering data. ... However, there is benefit in getting an mHealth solution to market quickly, independent of the regulatory or marketing claims, because it will provide the opportunity to gather data (similar to a

More from intelligence
Approximately 1 fully matching, plus 35 partially matching documents found.

Latest appointments

  • Future Thinking appoints Mohamed Muhsin as UK pharma head Future Thinking appoints Mohamed Muhsin as UK pharma head

    Muhsin joins from QuintilesIMS Health, where he was therapy lead, oncology and prior to that he was a senior market analyst at Roche. ... Both Muhsin and Bonrepaux-Caux will be focusing on expanding Future Thinking’s global footprint, technical

  • LaingBuisson names chairman and CEO LaingBuisson names chairman and CEO

    LaingBuisson, a UK healthcare market intelligence provider, has named Stephen Dorrell and Henry Elphick as its chairman and chief executive officer, respectively. ... Elphick said: “ LaingBuisson is already a trusted advisor to its clients and plays a

  • Natasha Giordano joins PLx Pharma Natasha Giordano joins PLx Pharma

    I look forward to building on the compelling clinical data and initial market access work the PLx management team has begun and to successfully launching PL2200 Aspirin into the U.S. ... market in 2017.”.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics